Anika Therapeutics, Inc.: accounts_receivable
| Value | {"amount": 20771000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-09-30) |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bb6f73c9-a911-45aa-8160-0bbe1e8c1285
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-18-007266Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/accounts-receivable/2018-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bb6f73c9-a911-45aa-8160-0bbe1e8c1285
History
- no predecessors — first report